Dopamine function, inflammation and connectivity in PTSD

PTSD 中的多巴胺功能、炎症和连接

基本信息

  • 批准号:
    9973958
  • 负责人:
  • 金额:
    $ 76.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-11 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The objective of this research proposal is to assess changes in stress-induced dopamine function and inflammatory response with connectivity and behavioral symptoms in posttraumatic stress disorder (PTSD). Imaging studies of PTSD from our group and others have described altered activation and functional connectivity between a variety of brain regions including the medial prefrontal cortex (mPFC), amygdala, and hippocampus. Despite increasing knowledge of circuit dysfunction in PTSD, functional neuroimaging studies performed to date have not provided adequate information about neurotransmitter systems and neurobiological pathways that affect such circuits to maintain PTSD symptoms. PTSD is an important public health problem that affects 7 to 8 % of the general population with higher rates of occurrence in victims of sexual abuse (10%). Psychosocial stress and trauma activate neuroendocrine and immune systems and elevate circulating concentrations of inflammatory markers. Activation of the immune system and release of inflammatory cytokines disrupts the mesocortical/limbic dopamine system and are associated with symptoms of anxiety, re-experiencing, arousal and avoidance that are prominent in PTSD. Findings from our group demonstrate blunted release of dopamine, as measured by microdialysis, in a cytokine-induced inflammatory animal models. Elevated inflammatory markers (e.g. plasma CRP and cytokines) were also associated with disrupted mesolimbic and mesocortical circuits, including decreased ventral striatum and amygdala to mPFC functional connectivity, in association with symptoms of anxiety in major depressive disorder, and particularly in patients with comorbid PTSD. Functional brain imaging studies to date have outlined a neural circuitry of PTSD but these imaging measures provide only general measures of brain function (e.g. blood flow) and do not address specific neurochemical pathways. The proposed research will address this knowledge gap by examining the following questions 1) Is stress-induced prefrontal and limbic DA neurotransmission reduced in patients with PTSD?, 2) Are stress-induced inflammatory biomarkers higher in PTSD and associated with symptom severity? and 3) Are disruptions in resting measures of functional behavior and connectivity associated with PTSD and symptom severity? Our proposed work builds on our laboratory’s experience in imaging PTSD including demonstration of blood flow and blood oxygen level-dependent reductions in mPFC function. Our long-term goal is to improve our mechanistic framework of stress-induced dopaminergic function and the inflammatory response in PTSD, and to identify mechanisms that can predict PTSD symptoms and their severity that may improve future treatment approaches.
项目摘要 这项研究的目的是评估压力诱导的多巴胺功能的变化, 创伤后应激障碍炎症反应与连接性和行为症状 (PTSD)。我们小组和其他人对创伤后应激障碍的成像研究描述了激活和功能的改变, 各种大脑区域之间的连接,包括内侧前额叶皮层(mPFC),杏仁核, 海马体。尽管对PTSD中回路功能障碍的认识越来越多,但功能性神经影像学研究 迄今为止进行的研究还没有提供关于神经递质系统和神经生物学的足够信息。 影响这些回路以维持创伤后应激障碍症状的途径。创伤后应激障碍是一个重要的公共卫生问题, 影响到7%至8%的普通人口,性虐待受害者的发生率更高(10%)。 心理社会压力和创伤激活神经内分泌和免疫系统, 炎症标志物的浓度。激活免疫系统和释放炎性细胞因子 破坏中皮层/边缘多巴胺系统,并与焦虑,再体验, 这在创伤后应激障碍中很突出我们小组的研究结果表明, 多巴胺,如通过微透析测量的,在马槟榔碱诱导的炎症动物模型中。升高 炎症标志物(如血浆CRP和细胞因子)也与破坏的中脑边缘和 中皮层回路,包括腹侧纹状体和杏仁核与mPFC的功能连接减少, 与重度抑郁症患者的焦虑症状相关,特别是在共病患者中 创伤后应激障碍迄今为止,功能性脑成像研究已经概述了创伤后应激障碍的神经回路,但这些成像 测量仅提供大脑功能的一般测量(例如血流量),而不涉及特定的 神经化学途径拟议的研究将通过审查以下内容来解决这一知识差距 问题1)在PTSD患者中,压力诱导的前额叶和边缘DA神经传递是否减少?(二) 应激诱导的炎症生物标志物在PTSD中是否更高并与症状严重程度相关?(3)是 与PTSD和症状相关的功能行为和连接的静息测量中断 严重性?我们提出的工作建立在我们实验室在创伤后应激障碍成像方面的经验基础上,包括证明 mPFC功能的血流量和血氧水平依赖性降低。我们的长期目标是提高我们的 应激诱导的多巴胺能功能和PTSD炎症反应的机制框架,以及 确定可以预测PTSD症状及其严重程度的机制,以改善未来的治疗 接近。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Douglas Bremner其他文献

James Douglas Bremner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Douglas Bremner', 18)}}的其他基金

Transcutaneous Vagal Nerve Stimulation in Veterans with Posttraumatic Stress Disorder
患有创伤后应激障碍的退伍军人的经皮迷走神经刺激
  • 批准号:
    10478766
  • 财政年份:
    2022
  • 资助金额:
    $ 76.88万
  • 项目类别:
Non-Invasive Vagal Nerve Stimulation in Veterans with Mild Traumatic Brain Injury (mTBI)
对患有轻度创伤性脑损伤 (mTBI) 的退伍军人进行无创迷走神经刺激
  • 批准号:
    10311521
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Dopamine function, inflammation and connectivity in PTSD
PTSD 中的多巴胺功能、炎症和连接
  • 批准号:
    10405521
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders
阿片类药物使用障碍患者的无创迷走神经刺激
  • 批准号:
    10402169
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders
阿片类药物使用障碍患者的无创迷走神经刺激
  • 批准号:
    10718694
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Non-Invasive Vagal Nerve Stimulation in Veterans with Mild Traumatic Brain Injury (mTBI)
对患有轻度创伤性脑损伤 (mTBI) 的退伍军人进行无创迷走神经刺激
  • 批准号:
    10543080
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Dopamine function, inflammation and connectivity in PTSD
PTSD 中的多巴胺功能、炎症和连接
  • 批准号:
    10657425
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
Non invasive vagal nerve stimulation in opioid use disorders
阿片类药物使用障碍中的无创迷走神经刺激
  • 批准号:
    10376890
  • 财政年份:
    2020
  • 资助金额:
    $ 76.88万
  • 项目类别:
A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTS
正念冥想疗法治疗 PTS 的多中心随机对照试验
  • 批准号:
    8453248
  • 财政年份:
    2012
  • 资助金额:
    $ 76.88万
  • 项目类别:
A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTS
正念冥想疗法治疗 PTS 的多中心随机对照试验
  • 批准号:
    8264703
  • 财政年份:
    2012
  • 资助金额:
    $ 76.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了